随着人口逐渐老龄化,多发性骨髓瘤(MM)在老年疾病中所占的比例越来越大,大多数患者的治疗仍以化疗为主,化疗方案多种多样,但左旋苯丙氨酸氮芥(商品名:马法兰)加醋酸泼尼松(商品名:强的松),简称MP方案,仍被认为是初治患者的标准方案。然而临床上发现相当一部分患者采用MP方案化 With the gradual population aging, the proportion of multiple myeloma (MM) in elderly diseases is increasing. Most of the patients are still treated with chemotherapy, and chemotherapy regimens are varied. However, L-phenylalanine Nitrogen mustard (trade name: melphalan) plus prednisone acetate (trade name: prednisone), referred to as the MP regimen, is still considered the standard regimen for first-time patients. However, a considerable number of patients found clinically MP program